Get started
Author

Sofía Bordet

The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene
2021 · Tamara Kobiec, Matilde Otero-Losada, et al. · Frontiers in Synaptic Neuroscience · 38
PDF
A systematic review and meta-analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson’s disease
2022 · Débora Loureiro, Rodrigo Bilbao, et al. · Neurological Sciences · 28
Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
2021 · Lucas Udovin, Matilde Otero-Losada, et al. · Parkinsonism & Related Disorders · 24
PDF
The Genetic Basis of Probable REM Sleep Behavior Disorder in Parkinson’s Disease
2023 · Santiago Pérez-Lloret, Guenson Chevalier, et al. · Brain Sciences · 13
PDF
Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease, Results from a Cross-Sectional In Silico Study
2023 · Guenson Chevalier, Lucas Udovin, et al. · Brain Sciences · 13
PDF
An Open‐Label, Non‐randomized, Drug‐Repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 ( AT1 ) Receptor Antagonists on Anxiety and Depression in Parkinson's Disease
2025 · Sofia Bordet, Lina Grasso, et al. · Movement Disorders Clinical Practice · 11
PDF
Raloxifene Protects Oxygen-Glucose-Deprived Astrocyte Cells Used to Mimic Hypoxic-Ischemic Brain Injury
2024 · Nicolás Toro-Urrego, Juan P. Luaces, et al. · International Journal of Molecular Sciences · 5
Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective
2023 · Sofía Bordet, Juan Pablo Luaces, et al. · Frontiers in Neuroscience · 5
PDF
Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic
2020 · Matilde Otero-Losada, Tamara Kobiec, et al. · Frontiers in Neurology · 5
PDF
MicroRNAs and rs1803274 SNP-based BuChe downregulation are associated with metabolic syndrome through ghrelin hydrolysis and expression quantitative trait loci regulation in PD patients
2025 · Guenson Chevalier, Lucas Udovin, et al. · Frontiers in Molecular Neuroscience · 1
PDF
Metabolic Syndrome and Parkinson’s Disease: Two Villains Join Forces
2025 · Lucas Udovin, Sofía Bordet, et al. · Brain Sciences · 1
PDF
Correction to: A systematic review and meta‑analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson’s disease
2023 · Débora Loureiro, Rodrigo Bilbao, et al. · Neurological Sciences · 1
PDF
Evaluation of the Damage and Neuroprotective Effects in the Central Nervous System Using a Model of Perinatal Asphyxia
2024 · Francisco Capani, Nicolas Toro Urrego, et al. · Microscopy and Microanalysis
Partial Neuroprotection From Neurodevelopmental Impairment by Environmental Enrichment in Experimental Perinatal Asphyxia
2023 · Tamara Kobiec, Camila Meloni, et al. · IBRO Neuroscience Reports
PDF
Neuroprotection during Hypoxia using Steroids Analogues
2023 · Nicolas Toro-Urrego, Tamara Kobiec, et al. · Microscopy and Microanalysis
PDF
Phenotypic Differences among Recently Diagnosed Drug-Naïve Patients with Parkinson’s Disease with or without SNCA Polymorphisms
2023 · Santiago Pérez-Lloret, Alejandro Enet, et al. · Preprints.org
PDF
Biological Markers to Study the Morphological Modifications Induced by Perinatal Asphyxia
2022 · Rodolfo Kolliker-Frers, Juan Pablo Luaces, et al. · Microscopy and Microanalysis
Works count: 17
Citation count: 145
H-index: 6
I10-index: 6
Year
Topic
Type